Nurse Practitioner, Family · Philadelphia, PA
NPI
1043520018
Since 2010
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
909 Walnut St Fl 2
Philadelphia, PA, 19107
Phone (215) 955-7952
Groups this clinician bills Medicare through
Medicare paid, 2024
$2,478
63 services
Medicare patients, 2024
45
Average age 55
Drug cost, 2024
$2.8M
4,125 prescriptions
Company payments, 2025
$160
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kelly Pearson-Caravetta was code 99214 (office e&m - established), 20 times for 20 patients. In total Kelly Pearson-Caravetta billed 63 services in 8 codes, and Medicare paid $2,478.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-11-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 20 | 20 | $66.55 | $1,331 |
| 95970 Electrical Nerve Conductivity | Facility | 18 | 14 | $12.45 | $224 |
By year: 2022 $1,584 for 29 services; 2023 $1,367 for 41 services; 2024 $2,478 for 63 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kelly Pearson-Caravetta prescribed most often to Medicare patients was Lacosamide, with 605 prescriptions and refills. In total Kelly Pearson-Caravetta wrote 4,125 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lacosamide Generic | 605 | 927 | 125 | $88K |
| Xcopri Cenobamate | 545 | 612 | 88 | $1.0M |
| Levetiracetam Generic | 305 | 619 | 97 | $9,832 |
| Briviact Brivaracetam | 258 | 278 | 40 | $416K |
| Lamotrigine Generic | 243 | 600 | 74 | $5,600 |
| Clobazam Generic | 132 | 173 | 26 | $16K |
| Topiramate Generic | 122 | 214 | 29 | $2,197 |
| Divalproex Sodium Generic | 108 | 218 | 26 | $4,354 |
| Zonisamide Generic | 108 | 231 | 32 | $4,521 |
| Phenobarbital Generic | 99 | 165 | 18 | $2,673 |
| Clonazepam Generic | 96 | 117 | 26 | $706 |
| Nayzilam Midazolam | 86 | 86 | 36 | $82K |
| Oxcarbazepine Generic | 82 | 139 | 19 | $5,922 |
| Fycompa Perampanel | 77 | 83 | 15 | $94K |
| Gabapentin Generic | 74 | 152 | 23 | $1,411 |
Brand drugs: 1,258 claims; generic drugs: 2,767 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kelly Pearson-Caravetta $160 ($160 in general payments such as food, travel and fees) from 2 companies. The largest payer was SK Life Science, Inc. with $128.
| Company | Payments | Amount |
|---|---|---|
| SK Life Science, Inc. | 1 | $128 |
| UCB, Inc. UCB.BR | 1 | $31.49 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.